• Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination 

  Zaloum, SA; Wood, CH; Tank, P; Upcott, M; Vickaryous, N; Anderson, V; Baker, D; Chance, R; Evangelou, N; George, K (2023)

• Early depressive symptoms and disability accrual in Multiple Sclerosis: a UK MS Register study 

  Jacobs, BMM; Daruwalla, C; McKeon, MOO; Al-Najjar, R; Simcock-Davies, A; Tuite-Dalton, K; Brown, JWL; Dobson, R; Rodgers, J; Middleton, R (2023)

• Nitrous oxide-induced myeloneuropathy: a case series 

  Mair, D; Paris, A; Zaloum, SA; White, LM; Dodd, KC; Englezou, C; Patel, F; Abualnaja, S; Lilleker, JB; Gosal, D (2023)

• Management of Possible Multiple Sclerosis. 

  Lee, CD; Galetta, SL; Dobson, R (2023-06-08)

• Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis during pregnancy and breastfeeding: A systematic review and Delphi consensus 

  Iyer, P; Wiles, K; Ismail, A; Nanda, S; Murray, K; Hughes, S; Ford, HL; Pearson, OR; White, S; Bonham, N (2023)

• Menopause in women with multiple sclerosis: clinical symptoms, therapeutic considerations and possible impact on the course of the disease 

  Dobson, R (MA Healthcare, 2023-02-07)

• Gender Differences in the Prevalence of Parkinson's Disease 

  Zirra, A; Rao, SC; Bestwick, J; Rajalingam, R; Marras, C; Blauwendraat, C; Mata, I; Noyce, AJ (2023)

• Family planning and multiple sclerosis 

  Dobson, R (Elsevier, 2023-04-01)

• Polygenic risk score prediction of multiple sclerosis in individuals of South Asian ancestry 

  Breedon, JR; Marshall, CR; Giovannoni, G; van Heel, DA; Dobson, R; Jacobs, BM (2023)

• Risk of Suicide After Dementia Diagnosis. 

  Alothman, D; Card, T; Lewis, S; Tyrrell, E; Fogarty, AW; Marshall, CR (2022-10-03)

  IMPORTANCE: Patients with dementia may be at an increased suicide risk. Identifying groups at greatest risk of suicide would support targeted risk reduction efforts by clinical dementia services. OBJECTIVES: To examine the ...

• Social determinants of health in multiple sclerosis 

  Dobson, R; Rice, DR; D'hooghe, M; Horne, R; Learmonth, Y; Mateen, FJ; Marck, CH; Reyes, S; Williams, MJ; Giovannoni, G (2022)

• Ocrelizumab during pregnancy and lactation: Rationale and design of the MINORE and SOPRANINO studies in women with MS and their infants 

  Bove, R; Hellwig, K; Pasquarelli, N; Borriello, F; Dobson, R; Oreja-Guevara, C; Lin, C-J; Zecevic, D; Craveiro, L; McElrath, T (2022)

• Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis 

  Tallantyre, EC; Scurr, MJ; Vickaryous, N; Richards, A; Anderson, V; Baker, D; Chance, R; Evangelou, N; George, K; Giovannoni, G (2022)

• EVALUATING THE FEASIBILITY OF A REAL WORLD PHARMACOVIGILANCE STUDY (OPTIMISE:MS) 

  Dobson, R; Craner, M; Waddingham, E; Miller, A; Pindoria, J; Cavey, A; Matthews, PM (2022)

• Challenges and Opportunities of Real-World Data: Statistical Analysis Plan for the Optimise:MS Multicenter Prospective Cohort Pharmacovigilance Study 

  Waddingham, E; Miller, A; Dobson, R; Matthews, PM (2022)

• RISK FACTORS AND PARKINSON'S DISEASE PRESENTATIONS IN PRIMARY CARE IN A DIVERSE UK POPULATION 

  Simonet, C; Bestwick, J; Jitlal, M; Waters, S; Ben-Joseph, A; Mar-Shall, CR; Dobson, R; Jacobs, BM; Schrag, A; Noyce, AJ (2022)

• Rationale and design of a phase 4 study exploring B-cell levels and immune responses in infants born to women with MS who were exposed to ocrelizumab up to 6 months before or during the first trimester of pregnancy (the MINORE study) 

  Hellwig, K; Pasquarelli, N; Borriello, F; Bove, R; Dobson, R; Oreja-Guevara, C; Vukusic, S; Wei, W; Zecevic, D; Craveiro, L (2021)

• Pregnancy and infant outcomes in women receiving ocrelizumab for the treatment of multiple sclerosis 

  Dobson, R; Bove, R; Borriello, F; Craveiro, L; Ferreira, G; Hellwig, K; McElrath, T; Pasquarelli, N; Zecevic, D; Vukusic, S (2021)

• Updated results of the COVID-19 in MS global data sharing initiative validate consistent associations of anti-CD20 and other reported risk factors with severe COVID-19 outcomes 

  Simpson-Yap, S; Pirmani, A; De Brouwer, E; Geys, L; Parciak, T; Helme, A; Rijke, N; Kalincik, T; Hillert, J; Moreau, Y (2021)

• B-cell levels and immunity in breastfed infants of women with MS treated with ocrelizumab: design of a phase 4 study (SOPRANINO) 

  Bove, R; Pasquarelli, N; Borriello, F; Dobson, R; Hellwig, K; McElrath, T; Oreja-Guevara, C; Wei, W; Zecevic, D; Craveiro, L (2021)

View more